查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1825890

2025年全球红色生物技术市场报告

Red Biotechnology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，红色生物技术市场将快速成长，到2029年将达到9,378.5亿美元，复合年增长率为10.5%。预测期内成长的驱动因素包括个人化医疗的扩张、人口老化、研发投入、数位健康整合以及医疗基础设施的不断扩展。预测期内的全球趋势包括生技药品和生物仿製药的扩张、机器学习的整合、基于微生物组的治疗方法的开发、对罕见疾病和孤儿病的关注以及全球合作与伙伴关係。

未来五年的预测成长率为10.5%，较我们先前对该市场的预测略有下降0.7%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能对美国生物製药公司构成重大挑战，因为它将限制从美国和中国进口的CRISPR（成簇规律间隔短回文重复序列）-Cas9基因编辑套件，阻碍再生医学试验，并可能增加治疗开发成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，关税的影响可能更为广泛。

个人化医疗的需求日益增长，预计红色生物技术市场将迎来成长。个人化医疗是指根据个人特征（例如遗传和生活习惯）客製化治疗方案，以优化疗效并减少副作用。这种需求的驱动因素包括：更有效的治疗方法的潜力、基因组学的进步、日益复杂的疾病以及支持性法规的出台。红色生物技术利用遗传讯息，根据患者的基因图谱和疾病特征量身订做治疗方案，从而促进个人化医疗的发展。例如，个人化医疗联盟于2024年2月报告称，FDA在2023年核准了16种针对罕见疾病的新型个人化治疗方案，而2022年仅批准了6种。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球红色生物技术：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球红色生物技术市场：成长率分析
  • 全球红色生物技术市场表现：规模与成长，2019-2024
  • 全球红色生物技术市场预测：2024-2029年及2034年规模与成长
  • 全球红色生物技术：总目标市场（TAM）

第六章 市场细分

  • 全球红色生物技术市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单株抗体
  • 多株抗体
  • 重组蛋白
  • 疫苗
  • 基于细胞的免疫疗法产品
  • 基因治疗产品
  • 细胞治疗产品
  • 组织工程产品
  • 其他产品
  • 全球红色生物技术市场：按应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 药物研发
  • 动物生物技术
  • 环境生物技术
  • 医学生物技术
  • 工业生物技术
  • 农业生物技术
  • 其他用途
  • 全球红色生物技术市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 生物製药业
  • 契约製造组织 (CMO) 和合约研究组织 (CRO)
  • 其他最终用户
  • 全球红色生物技术市场：单株抗体细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 治疗性单株抗体
  • 诊断性单株抗体
  • 单株抗体生物相似药
  • 标靶单株抗体（癌症、自体免疫疾病）
  • 全球红色生物技术市场：多株抗体（按类型）、实际及预测（2019-2024 年、2024-2029 年、2034 年）
  • 诊断性多多株抗体
  • 治疗性多株多株抗体
  • 兽用多株多株抗体
  • 调查多多株抗体
  • 全球红色生物技术市场：重组蛋白细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 酵素替代疗法
  • 生长因子和荷尔蒙
  • 凝血因子浓缩物
  • 干扰素和细胞激素
  • 全球红色生物技术市场：依疫苗类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 预防性疫苗（流感、COVID-19、HPV）
  • 治疗性疫苗（癌症疫苗）
  • 基于DNA或RNA的疫苗
  • 蛋白质次单元疫苗
  • 全球红色生物技术市场：细胞免疫治疗产品细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • Car-T细胞疗法
  • T细胞受体治疗
  • NK细胞疗法
  • 基于树突状细胞的免疫疗法
  • 全球红色生物技术市场：基因治疗产品细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 基因编辑（基于 Crispr 的治疗方法）
  • 基于病毒载体的基因治疗
  • 基因静默疗法
  • 体内基因治疗产品
  • 全球红色生物技术市场：按细胞治疗产品类型、绩效和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 干细胞疗法
  • 再生细胞疗法（间质干细胞）
  • 自体细胞治疗
  • 同种异体细胞治疗
  • 全球红色生物技术市场：依组织工程产品细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 皮肤和软骨工程产品
  • 骨骼和肌肉再生产品
  • 心血管组织工程
  • 神经组织工程
  • 全球红色生物技术市场：依产品类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 血液和血液成分（例如血液替代品）
  • 蛋白质治疗学
  • 诊断试剂套件和工具（生物标记、检测试剂）
  • 再生医学产品

第七章 区域和国家分析

  • 全球红色生物技术市场：区域表现与预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球红色生物技术市场：各国状况、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 红色生物技术市场：竞争格局
  • 红色生物技术市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • GSK plc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Gilead Sciences
  • Amgen Inc.
  • Merck KGaA
  • Moderna Inc.
  • Regeneron Pharmaceuticals Inc.
  • Astellas Pharma Inc.
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • BioMarin Pharmaceutical Inc.
  • Vir Biotechnology
  • Alnylam Pharmaceuticals, Inc.
  • Ultragenyx Pharmaceutical
  • BioCryst Pharmaceuticals

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年红色生物技术市场：提供新机会的国家
  • 2029年红色生物技术市场：细分领域带来新机会
  • 2029年红色生物技术市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r31095u

Red biotechnology, a branch of biotechnology, focuses on medical and pharmaceutical applications, utilizing biological systems and organisms to develop products and technologies for healthcare. These include pharmaceuticals, diagnostic tests, and therapies to treat diseases and enhance human health.

The main products in red biotechnology encompass monoclonal antibodies, polyclonal antibodies, recombinant proteins, vaccines, cell-based immunotherapy products, gene therapy products, cell therapy products, tissue-engineered products, among others. Monoclonal antibodies, for instance, are lab-made proteins that mimic the immune system's ability to combat pathogens, finding application in targeted therapies for conditions such as cancer and autoimmune disorders. Red biotechnology spans drug discovery, animal biotechnology, environmental biotechnology, medical biotechnology, industrial biotechnology, agricultural biotechnology, catering to end-users such as the biopharmaceutical industry, contract manufacturing organizations (CMOs), contract research organizations (CROs), research institutes, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The red biotechnology market research report is one of a series of new reports from The Business Research Company that provides red biotechnology market statistics, including the red biotechnology industry global market size, regional shares, competitors with the red biotechnology market share, detailed red biotechnology market segments, market trends, and opportunities, and any further data you may need to thrive in the red biotechnology industry. These red biotechnology market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The red biotechnology market size has grown rapidly in recent years. It will grow from $566.28 billion in 2024 to $629.69 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to advancements in genetic engineering, stem cell research, growth of biotech startups, regulatory frameworks, biotech funding, and investment.

The red biotechnology market size is expected to see rapid growth in the next few years. It will grow to $937.85 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to the expansion of personalized medicine, the aging population, investment in research and development, digital health integration, and the expansion of healthcare infrastructure. Major trends in the forecast period include the expansion of biologics and biosimilars, integration of machine learning, development of microbiome-based therapies, focus on rare and orphan diseases, global collaboration, and partnerships.

The forecast of 10.5% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. biopharma by restricting access to Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 gene editing kits imported from Sweden and China, potentially stalling regenerative medicine trials and increasing therapeutic development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The red biotechnology market is set to experience growth, driven by the increasing demand for personalized medicine. Personalized medicine tailors medical treatment to individual characteristics such as genetics or lifestyle to optimize effectiveness and reduce adverse effects. This demand is fueled by the potential for more effective treatments, advances in genomics, growing disease complexities, and supportive regulations. Red biotechnology facilitates the development of personalized medicines by leveraging genetic information to customize treatments based on a patient's genetic profile and disease attributes. For example, in February 2024, the FDA approved 16 novel personalized therapies for rare diseases in 2023, compared to six in 2022, as reported by the Personalized Medicine Coalition.

Leading companies in the red biotechnology sector are concentrating on developing innovative products such as biosimilars to cater to the rising demand for personalized medicine and tackle disease complexities. Biosimilars are biological products closely resembling existing approved reference biologics, offering cost-effective alternatives. For instance, in June 2022, Amgen Inc. obtained FDA approval for Riabni (rituximab-arrx), a biosimilar to Rituxan (rituximab), for treating adults with moderate to severe rheumatoid arthritis (RA). This milestone underscores the development of biosimilars, designed to mimic existing biological products at lower costs.

In March 2023, Ipsen Biopharmaceuticals Inc. acquired Albireo Pharma Inc. to enhance its Rare Disease portfolio with therapies for rare cholestatic liver diseases. Albireo Pharma Inc. specializes in novel bile acid modulators for orphan pediatric liver diseases, contributing to Ipsen's scientific and commercial capabilities.

Major companies operating in the red biotechnology market are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Bristol-Myers Squibb Company, GSK plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences, Amgen Inc., Merck KGaA, Moderna Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Boehringer Ingelheim International GmbH, BioMarin Pharmaceutical Inc., Vir Biotechnology, Alnylam Pharmaceuticals, Inc., Ultragenyx Pharmaceutical, BioCryst Pharmaceuticals, Sangamo Therapeutics, Inc., Denali Therapeutics, Atara Biotherapeutics, Beam Therapeutics, Umoja Biopharma

North America was the largest region in the red biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the red biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the red biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The red biotechnology market consists of sales of diagnostic testing kits, biological sensors, regenerative medicine, and antibiotics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Red Biotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on red biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for red biotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The red biotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Proteins; Vaccines; Cell-Based Immunotherapy Products; Gene Therapy Products; Cell Therapy Products; Tissue-Engineered Products; Other Products
  • 2) By Application: Drug Discovery And Development; Animal Biotechnology; Environmental Biotechnology; Medical Biotechnology; Industrial Biotechnology; Agricultural Biotechnology; Other Applications
  • 3) By End-User: Biopharmaceutical Industry; Contract Manufacturing Organization (CMO) And Contract Research Organization (CRO) Research Institutes; Other End Users
  • Subsegments:
  • 1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies; Diagnostic Monoclonal Antibodies; Biosimilars Of Monoclonal Antibodies; Targeted Monoclonal Antibodies (For Cancer, Autoimmune Diseases)
  • 2) By Polyclonal Antibodies: Diagnostic Polyclonal Antibodies; Therapeutic Polyclonal Antibodies; Veterinary Polyclonal Antibodies; Research Polyclonal Antibodies
  • 3) By Recombinant Proteins: Enzyme Replacement Therapies; Growth Factors And Hormones; Clotting Factor Products; Interferons And Cytokines
  • 4) By Vaccines: Preventive Vaccines (For Influenza, Covid-19, Hpv); Therapeutic Vaccines (Cancer Vaccines); Dna Or Rna-Based Vaccines; Protein Subunit Vaccines
  • 5) By Cell-Based Immunotherapy Products: Car-T-Cell Therapies; T-Cell Receptor Therapies; Nk Cell Therapies; Dendritic Cell-Based Immunotherapies
  • 6) By Gene Therapy Products: Gene Editing (Crispr-Based Therapies); Viral Vector-Based Gene Therapies; Gene Silencing Therapies; In Vivo Gene Therapy Products
  • 7) By Cell Therapy Products: Stem Cell Therapies; Regenerative Cell Therapies (Mesenchymal Stem Cells); Autologous Cell Therapies; Allogeneic Cell Therapies
  • 8) By Tissue-Engineered Products: Skin And Cartilage Engineered Products; Bone And Muscle Regenerative Products; Cardiovascular Tissue Engineering; Neural Tissue Engineering
  • 9) By Other Products: Blood And Blood Components (E.g., Blood Substitutes); Protein Therapeutics; Diagnostic Kits And Tools (Biomarkers, Assays); Regenerative Medicine Products
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Bayer AG; Bristol-Myers Squibb Company; GSK plc.; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Gilead Sciences; Amgen Inc.; Merck KGaA; Moderna Inc.; Regeneron Pharmaceuticals Inc.; Astellas Pharma Inc.; Biogen Inc.; Boehringer Ingelheim International GmbH; BioMarin Pharmaceutical Inc.; Vir Biotechnology; Alnylam Pharmaceuticals, Inc.; Ultragenyx Pharmaceutical; BioCryst Pharmaceuticals; Sangamo Therapeutics, Inc.; Denali Therapeutics; Atara Biotherapeutics; Beam Therapeutics; Umoja Biopharma
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Red Biotechnology Market Characteristics

3. Red Biotechnology Market Trends And Strategies

4. Red Biotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Red Biotechnology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Red Biotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Red Biotechnology Market Growth Rate Analysis
  • 5.4. Global Red Biotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Red Biotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Red Biotechnology Total Addressable Market (TAM)

6. Red Biotechnology Market Segmentation

  • 6.1. Global Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Cell-Based Immunotherapy Products
  • Gene Therapy Products
  • Cell Therapy Products
  • Tissue-Engineered Products
  • Other Products
  • 6.2. Global Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Development
  • Animal Biotechnology
  • Environmental Biotechnology
  • Medical Biotechnology
  • Industrial Biotechnology
  • Agricultural Biotechnology
  • Other Applications
  • 6.3. Global Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Industry
  • Contract Manufacturing Organization (CMO) And Contract Research Organization (CRO) Research Institutes
  • Other End Users
  • 6.4. Global Red Biotechnology Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapeutic Monoclonal Antibodies
  • Diagnostic Monoclonal Antibodies
  • Biosimilars Of Monoclonal Antibodies
  • Targeted Monoclonal Antibodies (For Cancer, Autoimmune Diseases)
  • 6.5. Global Red Biotechnology Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Polyclonal Antibodies
  • Therapeutic Polyclonal Antibodies
  • Veterinary Polyclonal Antibodies
  • Research Polyclonal Antibodies
  • 6.6. Global Red Biotechnology Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme Replacement Therapies
  • Growth Factors And Hormones
  • Clotting Factor Products
  • Interferons And Cytokines
  • 6.7. Global Red Biotechnology Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Preventive Vaccines (For Influenza, Covid-19, Hpv)
  • Therapeutic Vaccines (Cancer Vaccines)
  • Dna Or Rna-Based Vaccines
  • Protein Subunit Vaccines
  • 6.8. Global Red Biotechnology Market, Sub-Segmentation Of Cell-Based Immunotherapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Car-T-Cell Therapies
  • T-Cell Receptor Therapies
  • Nk Cell Therapies
  • Dendritic Cell-Based Immunotherapies
  • 6.9. Global Red Biotechnology Market, Sub-Segmentation Of Gene Therapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Editing (Crispr-Based Therapies)
  • Viral Vector-Based Gene Therapies
  • Gene Silencing Therapies
  • In Vivo Gene Therapy Products
  • 6.10. Global Red Biotechnology Market, Sub-Segmentation Of Cell Therapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stem Cell Therapies
  • Regenerative Cell Therapies (Mesenchymal Stem Cells)
  • Autologous Cell Therapies
  • Allogeneic Cell Therapies
  • 6.11. Global Red Biotechnology Market, Sub-Segmentation Of Tissue-Engineered Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Skin And Cartilage Engineered Products
  • Bone And Muscle Regenerative Products
  • Cardiovascular Tissue Engineering
  • Neural Tissue Engineering
  • 6.12. Global Red Biotechnology Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood And Blood Components (E.g., Blood Substitutes)
  • Protein Therapeutics
  • Diagnostic Kits And Tools (Biomarkers, Assays)
  • Regenerative Medicine Products

7. Red Biotechnology Market Regional And Country Analysis

  • 7.1. Global Red Biotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Red Biotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Red Biotechnology Market

  • 8.1. Asia-Pacific Red Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Red Biotechnology Market

  • 9.1. China Red Biotechnology Market Overview
  • 9.2. China Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Red Biotechnology Market

  • 10.1. India Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Red Biotechnology Market

  • 11.1. Japan Red Biotechnology Market Overview
  • 11.2. Japan Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Red Biotechnology Market

  • 12.1. Australia Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Red Biotechnology Market

  • 13.1. Indonesia Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Red Biotechnology Market

  • 14.1. South Korea Red Biotechnology Market Overview
  • 14.2. South Korea Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Red Biotechnology Market

  • 15.1. Western Europe Red Biotechnology Market Overview
  • 15.2. Western Europe Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Red Biotechnology Market

  • 16.1. UK Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Red Biotechnology Market

  • 17.1. Germany Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Red Biotechnology Market

  • 18.1. France Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Red Biotechnology Market

  • 19.1. Italy Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Red Biotechnology Market

  • 20.1. Spain Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Red Biotechnology Market

  • 21.1. Eastern Europe Red Biotechnology Market Overview
  • 21.2. Eastern Europe Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Red Biotechnology Market

  • 22.1. Russia Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Red Biotechnology Market

  • 23.1. North America Red Biotechnology Market Overview
  • 23.2. North America Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Red Biotechnology Market

  • 24.1. USA Red Biotechnology Market Overview
  • 24.2. USA Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Red Biotechnology Market

  • 25.1. Canada Red Biotechnology Market Overview
  • 25.2. Canada Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Red Biotechnology Market

  • 26.1. South America Red Biotechnology Market Overview
  • 26.2. South America Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Red Biotechnology Market

  • 27.1. Brazil Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Red Biotechnology Market

  • 28.1. Middle East Red Biotechnology Market Overview
  • 28.2. Middle East Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Red Biotechnology Market

  • 29.1. Africa Red Biotechnology Market Overview
  • 29.2. Africa Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Red Biotechnology Market Competitive Landscape And Company Profiles

  • 30.1. Red Biotechnology Market Competitive Landscape
  • 30.2. Red Biotechnology Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GSK plc. Overview, Products and Services, Strategy and Financial Analysis

31. Red Biotechnology Market Other Major And Innovative Companies

  • 31.1. Takeda Pharmaceutical Company Limited
  • 31.2. Eli Lilly and Company
  • 31.3. Gilead Sciences
  • 31.4. Amgen Inc.
  • 31.5. Merck KGaA
  • 31.6. Moderna Inc.
  • 31.7. Regeneron Pharmaceuticals Inc.
  • 31.8. Astellas Pharma Inc.
  • 31.9. Biogen Inc.
  • 31.10. Boehringer Ingelheim International GmbH
  • 31.11. BioMarin Pharmaceutical Inc.
  • 31.12. Vir Biotechnology
  • 31.13. Alnylam Pharmaceuticals, Inc.
  • 31.14. Ultragenyx Pharmaceutical
  • 31.15. BioCryst Pharmaceuticals

32. Global Red Biotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Red Biotechnology Market

34. Recent Developments In The Red Biotechnology Market

35. Red Biotechnology Market High Potential Countries, Segments and Strategies

  • 35.1 Red Biotechnology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Red Biotechnology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Red Biotechnology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer